NEWS DETAIL

VectorY Have Been Selected as Winners of the Merck Millipore 2021 European Advance Biotech Program!

VectorY have been selected as winners of the Merck Millipore 2021 European Advance Biotech Program.

The Merck Millipore Advance Biotech Grant Program helps biotech startups to develop and advance the next generation of drugs to market. We look forward to accelerating the development and manufacture of next-generation gene therapies in collaboration with the Merck Millipore team!